Understanding Institutional Investors’ Interest in Psychedelics

Institutional investors are interested in the psychedelic medicine sector but they are not investing. So, what is holding them back and what would encourage them to take an equity position? FTI Consulting issued a survey to institutional investors in the UK and US to understand their level of interest in the sector, how they expect the sector to perform in the coming years and what are the catalysts to get them to invest.